Lifeboat Foundation

I’ve been reading Scientific American for over 40 years, and it’s always giving me a good overview of topics that I’m unfamiliar with. I have come across a few recent articles on the topic of Banning Killer Robots. Here are web links to two excellent articles:

https://www.scientificamerican.com/my-account/login/?s=1

Nations racing to acquire weapons that choose their own targets are ignoring the apocalyptic scenarios that can unfold when rivals catch up.

Continue reading “Fully Autonomous Weapons Pose Unique Dangers to Humankind” »

Rasa cofounder Alan Nichol weighs in on Meena, Google’s latest attempt at conversational AI, and what it means for the future of AI assistants.

This article was written by AI

Can you tell?

What are AI applications?

Continue reading “AI: ‘The technology is very powerful and potentially very dangerous…’” »

Scientists from Tufts University, the University of Vermont, and the Wyss Institute at Harvard published early research in Proceedings of the National Academy of Sciences about robots made from heart and skin cells derived from frog embryo stem cells that they call xenobots. What does this mean for robotics and what are the ethical issues at play?

Starring tom merritt, sarah lane, len peralta, roger chang, annalee newitz.

Continue reading “Xenobots Have Heart (Cells) — DTNS 3700” »

Kansas City Chiefs or San Francisco 49ers? Let the swarm decide.

Remember the first time you tried Apple’s Siri and went absolutely gaga over the human-like qualities of the application? Well, then came Amazon’s Alexa, a virtual assistant AI that was first available in the Amazon Dot and Amazon Echo Dot speakers but none of these were conversational as such. Although they can answer general questions about the weather and news, it will never feel really conversational.

Google, however, has in store something more conversational than the existing Siri, Alexa and Cortana in the form of its new chat companion, Meena. The company claims that it is going to be the best chatbot in the market that can talk with the user about anything on earth.

Continue reading “Meet Meena, Google’s new chatbot that interacts like humans” »

Using digital ai generated medicines plus human on a chip systems you could get new medicines out not in years but hours.

The next generation of MOC design at TissUse aims for a Human-on-a-Chip, increasing the number of interconnected organs toward acceptable organismal complexity. This number of organs is supposed to be efficient to provide human organismal homeostasis, sufficiently flexible for diverse disease modelling and to bear the potential of ultimately replacing animal models for systemic substance testing.

A swarm of autonomous robots has been deployed by researchers from DARPA to test how the technology could be used as part of an urban raid. The experiment was part of a project to find ways to map environments and gather real-time intelligence using aerial and land based robots.

In the not-so-distant future, hundreds of unmanned drones and on-the-ground rovers could swoop into an area of interest and spew crucial data to human military operators faced with limited sight lines or tasked with navigating unpredictable spaces, researchers the Defense Advanced Research Projects Agency (DARPA) said this week.

A drug molecule invented entirely by artificial intelligence is set to enter human clinical trials for the first time, marking a critical milestone for the role of machine learning in medicine.

The new compound, which has been designed to treat patients with obsessive-compulsive disorder, was developed by Oxford-based AI start-up Exscientia in collaboration with the Japanese pharmaceutical firm Sumitomo Dainippon Pharma.

In a sharp acceleration of the typical path to drug development, which can take about four and a half years, the AI-designed compound reached the point of entering clinical trials within just 12 months.